Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

LaserSight's LaserScan 2000/LSX

This article was originally published in The Gray Sheet

  • News

Executive Summary

PMA is submitted for the scanning excimer laser platform. Data in support of the PMA were derived from a multicenter study evaluating use of the device to perform photorefractive keratectomy for treatment of myopia (nearsightedness) between -1.5 diopters and -10 D with less than or equal to 1 D astigmatism. LaserSight reports 1997 revenues (ended Dec. 31) of $24.4 mil, up 13% over 1996. Fourth-quarter revenues were flat at $6.3 mil. The company sells 13 laser systems in the fourth quarter, raising to 200 the total number of laser units sold to date

Table

View full table

Tags:
Latest Headlines

EU: Good News For IVDs And For Future Transparency Of Medtech Compliance

Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease

Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

See All
UsernamePublicRestriction

Register

MT009810

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By